PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
The Korean Journal of Internal Medicine10.3904/kjim.2011.26.2.1532011262153Retrospective Comparison of Levofloxacin and Moxifloxacin on Multidrug-Resistant Tuberculosis Treatment OutcomesJinwoo Lee, Chang-Hoon Lee, Deog Kyeom Kim, Ho Il Yoon, Jae Yeol Kim, Sang-Min Lee, Seok-Chul Yang, Jae Ho Lee, Chul-Gyu Yoo, Choon-Taek Lee, Hee Soon Chung, Young Whan Kim, Sung Koo Han, Jae-Joon Yimhttp://synapse.koreamed.org/pdf/10.3904/kjim.2011.26.2.153, http://synapse.koreamed.org/DOIx.php?id=10.3904/kjim.2011.26.2.153, http://www.kjim.org/upload/kjim-26-153.pdf
Reactions Weekly10.1007/s40278-019-64075-x201917591185-185Moxifloxacin/Bedaquilinehttp://link.springer.com/content/pdf/10.1007/s40278-019-64075-x.pdf, http://link.springer.com/article/10.1007/s40278-019-64075-x/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-019-64075-x.pdf
Respirology10.1111/resp.134522018243201-203Management of adverse reactions to high-dose moxifloxacin used in multidrug-resistant tuberculosis treatment programmesWing Wai Yew, Kwok Chiu Changhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fresp.13452, http://onlinelibrary.wiley.com/wol1/doi/10.1111/resp.13452/fullpdf
The Lancet Infectious Diseases10.1016/s1473-3099(10)70047-52010104215Treatment outcomes among patients with multidrug-resistant tuberculosisSonal S Munsiffhttps://api.elsevier.com/content/article/PII:S1473309910700475?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1473309910700475?httpAccept=text/plain
Respirology10.1111/resp.13419_14620182361-61TREND OF MULTIDRUG-RESISTANT TUBERCULOSIS OVER 20 YEARS: DRUG RESISTANCE, TREATMENT OUTCOMES, AND ADVERSE EVENTShttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fresp.13419_146, http://onlinelibrary.wiley.com/wol1/doi/10.1111/resp.13419_146/fullpdf
Open Forum Infectious Diseases10.1093/ofid/ofv133.44320152suppl_1Multidrug-Resistant Tuberculosis Treatment as Prevention: Modeling the Population-Level Impact of Expanded Treatment for Multidrug-Resistant TuberculosisEmily Kendall, Andrew Azman, Frank Cobelens, David Dowdyhttps://academic.oup.com/ofid/article/doi/10.1093/ofid/ofv133.443/2634932
BMC Public Health10.1186/s12889-018-5371-32018181Risk factors for the occurrence of multidrug-resistant tuberculosis among patients undergoing multidrug-resistant tuberculosis treatment in East Shoa, EthiopiaFanta Desissa, Tilaye Workineh, Takele Beyenehttp://link.springer.com/content/pdf/10.1186/s12889-018-5371-3.pdf, http://link.springer.com/article/10.1186/s12889-018-5371-3/fulltext.html, http://link.springer.com/content/pdf/10.1186/s12889-018-5371-3.pdf
Indian Journal of Tuberculosis10.1016/j.ijtb.2016.05.009201663164Presumptive treatment of multidrug-resistant tuberculosis in household contactshttps://api.elsevier.com/content/article/PII:S0019570716301275?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0019570716301275?httpAccept=text/plain
PharmacoEconomics & Outcomes News10.2165/00151234-200905890-00009200958918-8Levofloxacin trumps moxifloxacin for CAPhttp://link.springer.com/content/pdf/10.2165/00151234-200905890-00009.pdf, http://link.springer.com/article/10.2165/00151234-200905890-00009/fulltext.html, http://link.springer.com/content/pdf/10.2165/00151234-200905890-00009.pdf
PharmacoEconomics & Outcomes News10.2165/00151234-200805680-00008200856814-4Moxifloxacin, levofloxacin costs compared at Chest 2008http://link.springer.com/content/pdf/10.2165/00151234-200805680-00008.pdf, http://link.springer.com/article/10.2165/00151234-200805680-00008/fulltext.html, http://link.springer.com/content/pdf/10.2165/00151234-200805680-00008.pdf